about
Drug safety and efficacy evaluation of sertindole for schizophrenia.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.QT dynamics during treatment with sertindoleUpdate on the role of antipsychotics in the treatment of Tourette syndrome.Sertindole in schizophrenia: efficacy and safety issues.Differential effects of blockade of ERG channels on gamma oscillations and excitability in rat hippocampal slices.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sertindole for the treatment of schizophrenia.
@en
Sertindole for the treatment of schizophrenia.
@nl
type
label
Sertindole for the treatment of schizophrenia.
@en
Sertindole for the treatment of schizophrenia.
@nl
prefLabel
Sertindole for the treatment of schizophrenia.
@en
Sertindole for the treatment of schizophrenia.
@nl
P2093
P2860
P1476
Sertindole for the treatment of schizophrenia
@en
P2093
Arthur Kaladjian
Jean-Michel Azorin
Marc Adida
P2860
P304
P356
10.1517/14656566.2010.536217
P407
P50
P577
2010-12-01T00:00:00Z